Streetbeat News

Analyst Ratings

PD

Goldman Sachs analyst Kash Rangan has maintained a Neutral rating on PagerDuty (NYSE:PD) while lowering the price target from $24 to $21.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:25 pm

ABNB

Argus Research has downgraded Airbnb from Buy to Hold, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:22 pm

BANC

Stephens & Co. analyst Andrew Terrell has reiterated an Equal-Weight rating on Banc of California (NYSE:BANC) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:19 pm

ZS

Oppenheimer analyst Ittai Kidron maintains an Outperform rating on Zscaler but lowers the price target from $260 to $230.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:19 pm

AMZN

Deep-pocketed investors are showing a bullish sentiment towards Amazon.com (NASDAQ:AMZN) in the options market, with significant call options activity. The price target for AMZN is between $160 and $205, with a current trading price of $173.28. Analysts maintain an Overweight rating with a consensus target price of $233.33.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 2:16 pm

ZS

UBS analyst Roger Boyd maintains a Buy rating on Zscaler but lowers the price target from $270 to $250.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:16 pm

NFLX

Deep-pocketed investors are showing a bearish sentiment towards Netflix (NASDAQ:NFLX) through significant options activity. Despite a divided sentiment, with 47% bearish and 38% bullish, the focus is on a price range between $625 and $1040. Analysts maintain positive ratings with target prices between $750 and $900.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 2:15 pm

ASAN

UBS analyst Taylor McGinnis has maintained a Neutral rating on Asana (NYSE:ASAN) but has lowered the price target from $17 to $13.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:15 pm

TXG

Stephens & Co. analyst Mason Carrico has reiterated an Overweight rating on 10x Genomics (NASDAQ:TXG) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:15 pm

PRAX

Oppenheimer analyst Francois Brisebois has reiterated an Outperform rating for Praxis Precision Medicine (NASDAQ:PRAX) and increased the price target from $134 to $143.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:14 pm